[go: up one dir, main page]

DE60108775T8 - Methode zur behandlung von schlaganfall - Google Patents

Methode zur behandlung von schlaganfall Download PDF

Info

Publication number
DE60108775T8
DE60108775T8 DE60108775T DE60108775T DE60108775T8 DE 60108775 T8 DE60108775 T8 DE 60108775T8 DE 60108775 T DE60108775 T DE 60108775T DE 60108775 T DE60108775 T DE 60108775T DE 60108775 T8 DE60108775 T8 DE 60108775T8
Authority
DE
Germany
Prior art keywords
stroke
treatment
patient
administering
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60108775T
Other languages
English (en)
Other versions
DE60108775D1 (de
DE60108775T2 (de
Inventor
Allen James CLEMENS
David Basingstoke Hants LODGE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE60108775D1 publication Critical patent/DE60108775D1/de
Application granted granted Critical
Publication of DE60108775T2 publication Critical patent/DE60108775T2/de
Publication of DE60108775T8 publication Critical patent/DE60108775T8/de
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Liquid Crystal Substances (AREA)
  • Processing Of Stones Or Stones Resemblance Materials (AREA)
DE60108775T 2000-10-13 2001-09-28 Methode zur behandlung von schlaganfall Expired - Fee Related DE60108775T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24042200P 2000-10-13 2000-10-13
US240422P 2000-10-13
PCT/US2001/027738 WO2002032389A1 (en) 2000-10-13 2001-09-28 Method of treating stroke

Publications (3)

Publication Number Publication Date
DE60108775D1 DE60108775D1 (de) 2005-03-10
DE60108775T2 DE60108775T2 (de) 2006-01-12
DE60108775T8 true DE60108775T8 (de) 2006-08-24

Family

ID=22906451

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60108775T Expired - Fee Related DE60108775T8 (de) 2000-10-13 2001-09-28 Methode zur behandlung von schlaganfall

Country Status (8)

Country Link
EP (1) EP1330233B1 (de)
JP (1) JP2004511507A (de)
AT (1) ATE288254T1 (de)
AU (1) AU2002211217A1 (de)
CA (1) CA2420994A1 (de)
DE (1) DE60108775T8 (de)
ES (1) ES2236321T3 (de)
WO (1) WO2002032389A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378110B2 (en) 2002-12-17 2008-05-27 Med Immune Vaccines, Inc. High pressure spray-dry of bioactive materials
KR20060094421A (ko) * 2005-02-24 2006-08-29 고재영 신규한 뇌졸중 치료제 조성물
WO2022173888A1 (en) * 2021-02-10 2022-08-18 Eleusis Thereapeutics Us, Inc. Pharmaceutically acceptable salts of psilocin and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20000944A1 (es) * 1998-07-31 2000-09-20 Lilly Co Eli Derivados de sulfonamida

Also Published As

Publication number Publication date
ATE288254T1 (de) 2005-02-15
JP2004511507A (ja) 2004-04-15
EP1330233B1 (de) 2005-02-02
EP1330233A1 (de) 2003-07-30
ES2236321T3 (es) 2005-07-16
AU2002211217A1 (en) 2002-04-29
DE60108775D1 (de) 2005-03-10
DE60108775T2 (de) 2006-01-12
WO2002032389A1 (en) 2002-04-25
CA2420994A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
DE60101265D1 (de) Behandlung von augenschmerzen
GB0130677D0 (en) Medicaments and novel compounds
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60130030D1 (de) Verfahren zur behandlung von glaukom
DE60108775D1 (de) Methode zur behandlung von schlaganfall
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
SE0004827D0 (sv) Therapeutic compounds
DE60229047D1 (de) Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit
ATE449607T1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
DE60310975D1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne
DE60236894D1 (de) Behandlung von statin-nebenwirkungen mit uridinderivaten
DE60313344D1 (de) Verwendung von 4-pyridylmethyl-phthalazin-derivaten zur herstellung eines medikaments zur behandlung von myelodysplastischen syndromen
DE60003921D1 (de) Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung
DE60233353D1 (de) Verfahren zur behandlung von halitose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee